Long-term outcomes for duodenal adenocarcinoma
Part of Digestive system clinical trials.
This trial looks at how people with duodenal adenocarcinoma (a rare cancer in the first part of the small intestine) do over the long term. It uses data from your medical records and follow-up visits to understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of duodenal adenocarcinoma (a type of cancer in the first part of the small intestine) that is not in the ampulla of Vater.
- You cannot have any other gastrointestinal cancer (like stomach, colon, or pancreas cancer).
- Your medical records must be complete and available for review.
- You must be able to be followed up after your diagnosis.
- You must agree to let your clinical data be used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people do over time after having non-cancerous or early-stage growths in the duodenum or ampulla removed during an endoscopy. It aims to understand the long-term safety and effectiveness of this procedure.
This study looks at long-term outcomes after removing a growth in the duodenum or near the bile/pancreas opening (ampulla) using an endoscope. You may benefit by closely monitoring your recovery and long-term health after the procedure.
This study tests whether giving personalized follow-up treatment after stomach cancer surgery and chemotherapy can help prevent the cancer from coming back. The treatment plan is tailored based on how well the tumor responded to initial chemotherapy.
This study looks at whether a blood test for leftover cancer cells (called MRD) after stomach cancer surgery can help guide treatment. It is for people with a certain type of stomach cancer that has spread to nearby tissues but not to distant organs, and who are having surgery as their first treatment.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
This trial compares two ways of doing a major pancreas-and-duodenum operation: laparoscopic (small incisions) versus open surgery (larger incision). It aims to see which approach works better for nonpancreatic periampullary adenocarcinoma when the goal is cure.
Hear when a new Gastrointestinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.